Share
The pharma industry briefing
The latest news, approvals and clinical trials you need to know about this month
Data:
News in Numbers
Data: News in Numbers
16%
FDA new drug approvals down 16% in 2019, according to research from GlobalData
10%
CEPI has invested $384m in Novavax‘s COVID-19 vaccine candidate
$384m
5
Gilead is granting five generic drug manufacturers the rights to manufacture remdesivir
€45m
Norway’s BerGenBio has raised approximately €45.4m develop its pipeline
40
This year marks the 40th anniversary of the eradication of smallpox
Data: News in Numbers
16%
FDA new drug approvals down 16% in 2019, according to research from GlobalData
$384m
CEPI has invested $384m in Novavax‘s COVID-19 vaccine candidate
5
Gilead is granting five generic drug manufacturers the rights to manufacturer remdesivir
€45m
Norway’s BerGenBio has raised approximately €45.4m develop its pipeline
40
This year marks the 40th anniversary of the eradication of smallpox
Arthritis drug may improve respiratory function in some patients with severe COVID-19
A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients with severe Covid-19.
Source: World Pharma News
Pharma shipments lift Singapore exports for third straight month
Singapore's annual exports rose for the third straight month in April, bolstered by a sharp rise in pharmaceutical shipment.
Source: Yahoo
Spike in cyber-crime activity sparks official warning to Pharma industry
The UK’s National Cyber Security Centre along with the American Department of Homeland Security’s CISA have issued a specific warning to pharmaceutical companies, medical research organisations and universities.
Source: Two Birds
Trump says former Lilly exec will lead “Operation Warp Speed”
President Trump has named former GlaxoSmithKline executive Moncef Slaoui as chief adviser to "Operation Warp Speed", an effort to speed up development of a vaccine for COVID-19 in the US.
Source: Pharma Manufacturing
Approvals
Remdesivir
Gilead Sciences has received approval from the Japanese Ministry of Health, Labour and Welfare for its antiviral drug remdesivir to treat Covid-19 infection.
Source: Pharmaceutical Technology
Farxiga
The US Food and Drug Administration has approved AstraZeneca’s Farxiga (dapagliflozin) to reduce the risk of cardiovascular death and hospitalisation for heart failure in adults with heart failure with reduced ejection fraction.
Source: Pharmaceutical Technology
Qinlock (ripretinib) Tablets
Qinlock (ripretinib) is a broad-spectrum KIT and PDGFRα inhibitor for the treatment of patients with advanced gastrointestinal stromal tumour who have received prior treatment with three or more kinase inhibitors, including imatinib.
Source: FDA
Fensolvi (leuprolide acetate) Injection
Fensolvi (leuprolide acetate) is a gonadotropin releasing hormone agonist indicated for the treatment of paediatric patients two years of age and older with central precocious puberty.
Source: Biospace
Go to top
Go to top
Share this article
